<--- Back to Details
First PageDocument Content
Carbamates / Organofluorides / Cyclopropanes / Non-nucleoside reverse transcriptase inhibitors / Lopinavir/ritonavir / Lopinavir / Antiretroviral drug / Efavirenz / Nevirapine / Chemistry / Organic chemistry / Protease inhibitors
Date: 2013-11-14 03:55:58
Carbamates
Organofluorides
Cyclopropanes
Non-nucleoside reverse transcriptase inhibitors
Lopinavir/ritonavir
Lopinavir
Antiretroviral drug
Efavirenz
Nevirapine
Chemistry
Organic chemistry
Protease inhibitors

kaletra-tablets-and-oral-solution [removed]kaletra-tablets-and-oral-solution

Add to Reading List

Source URL: www.rxabbvie.com

Download Document from Source Website

File Size: 741,85 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

DocID: 1m6of - View Document

Microsoft Word - Biographie de JF Delfraissy BIS.doc

Microsoft Word - Biographie de JF Delfraissy BIS.doc

DocID: 1gw3d - View Document

Surveillance and outbreak reports  Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

DocID: 1gvMD - View Document

Questioning the HIV-AIDS hypothesis: 30 years of dissent

Questioning the HIV-AIDS hypothesis: 30 years of dissent

DocID: 1gtoc - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

DocID: 1gtlL - View Document